º´¿ø¾àÇÐ ¿¬±¸³í¹® °Ë»ö

º´¿ø¾àÇб³À°¿¬±¸¿ø¿¡ ¿À½Å °ÍÀ» ȯ¿µÇÕ´Ï´Ù.
´ç´¢º´ ȯÀÚÀÇ º¹¾à¼øÀÀµµ Çâ»óÀ» À§ÇÑ ¾à»çÀÇ Ä¡·áÀû ÁßÀçÈ°µ¿ÀÇ ºñ¿ë-È¿°ú ºÐ¼®(The cost-effectiveness evaluation for the pharmacist¡¯s therapeutic
intervention in type-2 diabetes patients)
Date

2009 ¤Ó ƯÁý

Authors
¾È¼º½É, ±èÀºÈñ, ±è¼øÁÖ, ³ªÇö¿Àa(°¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø ¾àÁ¦ºÎ, °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¾à¸®Çб³½Ça)
Keyword
diabetes, medication adherence, pharmacists intervention, cost effectiveness
Abstract

This study aimed to assess the cost effectiveness of pharmacists
intervention(improved dosing schedules: simplifying the regimen to daily dosing)to patients
with type 2 dibetes. From April to May 2010, 41 outpatients taking sulfonylurea as oral
hypoglycemic agent in endocrine department of Seoul St. Mary Hospital were divided into
two groups ; Group A kept taking sulfonylurea medication before meal while group B
changed the time of administration to immediately after meal. After follow-up until
November 2010, changes in compliance on medication measured by Morisky's scale(6:low,
6~7:medium, 8:high), HbA1C(%) and the cost were compared respectively. No significant
differences in compliance, HbA1c and the cost were found between two groups. However,
when the group B was divided into moderate compliance group(Morisky¡¯s scale¡Ã6) and poor
compliance group(Morisky¡¯s scale¡Â5), the compliance was significantly enhanced(1.3¡¾1.3
vs. -0.5¡¾0.8 p=0.0001) in the poor compliance group while there was no significant difference in HbA1c. Although the effects of the improved medication compliance on glycemic
control and the cost were not clearly investigated in this study, the findings of this study
indicated that medication compliance was improved by simplifying the regimen especially in the patients with poor compliance from the initial state. Further research with expanded
study period is needed to determine the effects of improved compliance on treatment outcome and the cost.

Publication
2011³â Vol.28 No.04
Abstract File
Full-Text
2009ƯÁý_¾È¼º½É.pdf